{"id":"W2800306828","doi":"10.2147/cmar.s162714","title":"Is progression-free survival a more relevant endpoint than overall survival in first-line HR+/HER2− metastatic breast cancer?","year":2018,"lang":"en","type":"article","venue":"Cancer Management and Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Novartis (Canada)","funders":"European Society for Medical Oncology","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Oncology; Progression-free survival; Hazard ratio; Clinical endpoint; Breast cancer; Cancer; Observational study; Randomized controlled trial; Quality of life (healthcare); Chemotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01816128,0.0006121519,0.005515577,0.004015832,0.0002914509,0.002635696,0.001186947,0.001826792,0.002858072],"category_scores_gemma":[0.05234715,0.0004047856,0.004927668,0.005202641,0.001240474,0.002539522,0.000735745,0.001499549,0.0002438968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0020587,"about_ca_system_score_gemma":0.002558299,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002089089,"about_ca_topic_score_gemma":0.003506186,"domain_scores_codex":[0.9878076,0.005741195,0.004226934,0.0008526923,0.001223186,0.0001484108],"domain_scores_gemma":[0.9311449,0.05180333,0.01381206,0.0005844043,0.002335888,0.0003194],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.003645723,0.00004785123,0.01078015,0.8502166,0.02454051,0.000131748,0.0002257104,0.0002367515,0.0003516705,0.000914695,0.002955341,0.1059532],"study_design_scores_gemma":[0.004904627,0.002425432,0.07940346,0.620589,0.217603,0.001737923,0.0009484178,0.0005235186,0.001151656,0.004543479,0.06596245,0.0002070007],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.003806107,0.9940323,0.0001624846,0.0008905244,0.0001667861,0.00009425553,0.0003726663,0.000002929449,0.0004719532],"genre_scores_gemma":[0.2038918,0.7876385,0.001458537,0.003933371,0.001175644,0.0008550446,0.0007621959,0.00001713422,0.0002677285],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9818387,"threshold_uncertainty_score":0.09604716,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09342696169412701,"score_gpt":0.4293813592579829,"score_spread":0.3359543975638559,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}